A healthcare company based out of North Carolina is turning heads so far during Tuesday’s session after the company announced that it plans to submit its Dordaviprone for...

To read the full story on AllPennyStocks.com, click here.

Chimerix (NASDAQ:CMRX)
過去 株価チャート
から 12 2024 まで 1 2025 Chimerixのチャートをもっと見るにはこちらをクリック
Chimerix (NASDAQ:CMRX)
過去 株価チャート
から 1 2024 まで 1 2025 Chimerixのチャートをもっと見るにはこちらをクリック